Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ramzi Abboud, M.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis, Missouri, United States
Amanda Cashen, M.D.Armin Ghobadi, M.D.Brad Kahl, M.D.Camille Abboud, M.D.Feng Gao, Ph.D.Geoffrey Uy, M.D.Iskra Pusic, M.D.John Dipersio, M.D., Ph.D.Keith Stockerl-Goldstein, M.D.Kelly Bolton, M.D.Mark Schroeder, M.D.Matt Christopher, M.D.Matthew Walter, M.D.Meagan Jacoby, M.D., Ph.D.Ramzi Abboud, M.D.Ravi Vij, M.D.Todd Fehniger, M.D., Ph.D.Zachary Crees, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2024
- Primary completion
- 8 Sept 2027
- Completion
- 27 Nov 2027
- Last update posted
- 22 Apr 2026
- Registered enrollment
- 41
- Registry id
- NCT06008808
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.